nodes	percent_of_prediction	percent_of_DWPC	metapath
Aspartame—SLC22A8—choroid plexus—malignant glioma	0.271	0.688	CbGeAlD
Aspartame—TRPV1—spinal cord—malignant glioma	0.0362	0.0922	CbGeAlD
Aspartame—TRPV1—central nervous system—malignant glioma	0.0294	0.0748	CbGeAlD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAE—malignant glioma	0.0276	0.0591	CbGpPWpGaD
Aspartame—Mitiglinide—PPARG—malignant glioma	0.0236	0.17	CrCbGaD
Aspartame—TRPV1—brain—malignant glioma	0.0233	0.0594	CbGeAlD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NTRK1—malignant glioma	0.0225	0.0482	CbGpPWpGaD
Aspartame—Lisdexamfetamine—SLC6A3—malignant glioma	0.0222	0.16	CrCbGaD
Aspartame—Ramipril—BCHE—malignant glioma	0.0213	0.153	CrCbGaD
Aspartame—TRPV1—Ion channel transport—ATP1B2—malignant glioma	0.0175	0.0374	CbGpPWpGaD
Aspartame—Bortezomib—PTGS1—malignant glioma	0.0173	0.124	CrCbGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—BAD—malignant glioma	0.0151	0.0323	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—BRAF—malignant glioma	0.0144	0.0308	CbGpPWpGaD
Aspartame—SLC22A6—brain—malignant glioma	0.0143	0.0365	CbGeAlD
Aspartame—Dextroamphetamine—SLC6A3—malignant glioma	0.0133	0.0953	CrCbGaD
Aspartame—Nateglinide—PPARG—malignant glioma	0.012	0.0864	CrCbGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—RAF1—malignant glioma	0.012	0.0257	CbGpPWpGaD
Aspartame—SLC22A8—central nervous system—malignant glioma	0.0108	0.0275	CbGeAlD
Aspartame—Amphetamine—SLC6A3—malignant glioma	0.0107	0.0768	CrCbGaD
Aspartame—TAS1R2—GPCR ligand binding—CCR4—malignant glioma	0.0106	0.0226	CbGpPWpGaD
Aspartame—Methamphetamine—SLC6A3—malignant glioma	0.00991	0.0712	CrCbGaD
Aspartame—TAS1R2—Signaling Pathways—LATS2—malignant glioma	0.00903	0.0193	CbGpPWpGaD
Aspartame—Nateglinide—PTGS1—malignant glioma	0.00888	0.0638	CrCbGaD
Aspartame—SLC22A8—brain—malignant glioma	0.00859	0.0218	CbGeAlD
Aspartame—TAS1R2—GPCR ligand binding—CXCR3—malignant glioma	0.00785	0.0168	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—malignant glioma	0.00778	0.0166	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.0076	0.0163	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—malignant glioma	0.00743	0.0159	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—BDKRB2—malignant glioma	0.00718	0.0154	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00695	0.0149	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—LATS1—malignant glioma	0.00684	0.0146	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—PIK3CA—malignant glioma	0.00683	0.0146	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—KNG1—malignant glioma	0.00653	0.014	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00608	0.013	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—APOD—malignant glioma	0.00591	0.0126	CbGpPWpGaD
Aspartame—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—AKT1—malignant glioma	0.00558	0.0119	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00545	0.0117	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CCR4—malignant glioma	0.00542	0.0116	CbGpPWpGaD
Aspartame—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00536	0.0115	CbGpPWpGaD
Aspartame—TRPV1—Stimuli-sensing channels—RAF1—malignant glioma	0.00528	0.0113	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MDK—malignant glioma	0.00462	0.00988	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DTX1—malignant glioma	0.00441	0.00943	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—F2—malignant glioma	0.00422	0.00903	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00416	0.00889	CbGpPWpGaD
Aspartame—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00409	0.00875	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCR3—malignant glioma	0.00403	0.00862	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—BDKRB2—malignant glioma	0.00369	0.00788	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00356	0.00761	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SUFU—malignant glioma	0.0035	0.00749	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00347	0.00742	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HEY2—malignant glioma	0.00346	0.0074	CbGpPWpGaD
Aspartame—TRPV1—Ion channel transport—RAF1—malignant glioma	0.00345	0.00737	CbGpPWpGaD
Aspartame—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00341	0.0073	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—GFAP—malignant glioma	0.00338	0.00723	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KNG1—malignant glioma	0.00335	0.00717	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPHK1—malignant glioma	0.00327	0.00699	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00326	0.00696	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HEY1—malignant glioma	0.0032	0.00685	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CCR4—malignant glioma	0.0032	0.00685	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIST1H3B—malignant glioma	0.00311	0.00666	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00303	0.00647	CbGpPWpGaD
Aspartame—TAS1R2—GPCR ligand binding—CXCL8—malignant glioma	0.00298	0.00636	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—MMP3—malignant glioma	0.00297	0.00635	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00285	0.00609	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAG2—malignant glioma	0.00284	0.00608	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00278	0.00595	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—APOD—malignant glioma	0.00277	0.00592	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00272	0.00581	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00265	0.00566	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00256	0.00548	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00248	0.00531	CbGpPWpGaD
Aspartame—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00244	0.00521	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—H3F3A—malignant glioma	0.0024	0.00514	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCR3—malignant glioma	0.00238	0.00509	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—YWHAE—malignant glioma	0.00232	0.00495	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NTRK2—malignant glioma	0.00232	0.00495	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FLT1—malignant glioma	0.00231	0.00493	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—DUSP6—malignant glioma	0.0023	0.00491	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—JAG1—malignant glioma	0.00227	0.00485	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00227	0.00485	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH3—malignant glioma	0.00226	0.00483	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FBXW7—malignant glioma	0.00222	0.00475	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BDKRB2—malignant glioma	0.00218	0.00466	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00217	0.00464	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—F2—malignant glioma	0.00217	0.00464	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.00211	0.00452	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CG—malignant glioma	0.00207	0.00444	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00207	0.00443	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PTPN11—malignant glioma	0.00204	0.00436	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH2—malignant glioma	0.00202	0.00433	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KNG1—malignant glioma	0.00198	0.00424	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00195	0.00418	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT2—malignant glioma	0.0019	0.00406	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NTRK1—malignant glioma	0.00189	0.00404	CbGpPWpGaD
Aspartame—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00186	0.00398	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CD—malignant glioma	0.00182	0.0039	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00181	0.00387	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.00176	0.00377	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP3—malignant glioma	0.00176	0.00375	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CDKN2B—malignant glioma	0.00174	0.00372	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTK2—malignant glioma	0.00169	0.00361	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HES1—malignant glioma	0.00166	0.00355	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NCOR1—malignant glioma	0.00165	0.00353	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00163	0.00349	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—RAF1—malignant glioma	0.00163	0.00348	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CB—malignant glioma	0.00159	0.0034	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFRA—malignant glioma	0.00158	0.00338	CbGpPWpGaD
Aspartame—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00155	0.00332	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—SPP1—malignant glioma	0.00153	0.00328	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—CXCL8—malignant glioma	0.00153	0.00327	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—IL2—malignant glioma	0.00146	0.00312	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TERT—malignant glioma	0.00145	0.00311	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PDGFB—malignant glioma	0.00142	0.00304	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00142	0.00303	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGFR1—malignant glioma	0.00141	0.00302	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—HIF1A—malignant glioma	0.00139	0.00297	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CAV1—malignant glioma	0.00135	0.00288	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KDR—malignant glioma	0.00133	0.00284	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.0013	0.00278	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—F2—malignant glioma	0.00128	0.00274	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FN1—malignant glioma	0.00128	0.00274	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BAD—malignant glioma	0.00127	0.00271	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—NOTCH1—malignant glioma	0.00125	0.00268	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00124	0.00265	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CD80—malignant glioma	0.00123	0.00263	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—APC—malignant glioma	0.00123	0.00262	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CG—malignant glioma	0.00123	0.00262	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGF—malignant glioma	0.00121	0.00259	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTPN11—malignant glioma	0.0012	0.00257	CbGpPWpGaD
Aspartame—TRPV1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.0012	0.00256	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—BRAF—malignant glioma	0.00115	0.00246	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT2—malignant glioma	0.00112	0.0024	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—EGFR—malignant glioma	0.00112	0.00239	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00108	0.00231	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CD—malignant glioma	0.00108	0.0023	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—KRAS—malignant glioma	0.00105	0.00226	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—FGF2—malignant glioma	0.00103	0.00221	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000993	0.00212	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—PIK3CA—malignant glioma	0.000969	0.00207	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MDM2—malignant glioma	0.000965	0.00206	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—RAF1—malignant glioma	0.000962	0.00206	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—ERBB2—malignant glioma	0.000951	0.00203	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000945	0.00202	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CB—malignant glioma	0.000939	0.00201	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CXCL8—malignant glioma	0.000902	0.00193	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000902	0.00193	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—CASP3—malignant glioma	0.000864	0.00185	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—IL2—malignant glioma	0.000862	0.00184	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000828	0.00177	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MMP9—malignant glioma	0.000816	0.00175	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PTEN—malignant glioma	0.000811	0.00174	CbGpPWpGaD
Aspartame—TAS1R2—Signaling by GPCR—AKT1—malignant glioma	0.000791	0.00169	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000789	0.00169	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—VEGFA—malignant glioma	0.000733	0.00157	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—STAT3—malignant glioma	0.000726	0.00155	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—MYC—malignant glioma	0.000674	0.00144	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—EGFR—malignant glioma	0.000659	0.00141	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—KRAS—malignant glioma	0.000623	0.00133	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—PIK3CA—malignant glioma	0.000572	0.00122	CbGpPWpGaD
Aspartame—SLC22A11—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000561	0.0012	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—TP53—malignant glioma	0.000554	0.00118	CbGpPWpGaD
Aspartame—TAS1R2—Signaling Pathways—AKT1—malignant glioma	0.000468	0.001	CbGpPWpGaD
Aspartame—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000428	0.000916	CbGpPWpGaD
Aspartame—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000357	0.000764	CbGpPWpGaD
